These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 23117024)
41. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration. Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456 [TBL] [Abstract][Full Text] [Related]
42. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel. Li J; Yin T; Wang L; Yin L; Zhou J; Huo M Int J Pharm; 2015 Apr; 483(1-2):38-48. PubMed ID: 25655715 [TBL] [Abstract][Full Text] [Related]
43. Antitumor activity of drug loaded glycyrrhetinic acid modified alginate nanoparticles on mice bearing orthotopic liver tumor. Zhang C; Wu Y; Liu T; Zhao Y; Wang X; Wang W; Yuan Z J Control Release; 2011 Nov; 152 Suppl 1():e111-3. PubMed ID: 22195787 [No Abstract] [Full Text] [Related]
44. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988 [TBL] [Abstract][Full Text] [Related]
45. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma. Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773 [TBL] [Abstract][Full Text] [Related]
46. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. He M; Zhao Z; Yin L; Tang C; Yin C Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302 [TBL] [Abstract][Full Text] [Related]
47. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles. Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076 [TBL] [Abstract][Full Text] [Related]
48. Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery. Wu P; Liu Q; Li R; Wang J; Zhen X; Yue G; Wang H; Cui F; Wu F; Yang M; Qian X; Yu L; Jiang X; Liu B ACS Appl Mater Interfaces; 2013 Dec; 5(23):12638-45. PubMed ID: 24274601 [TBL] [Abstract][Full Text] [Related]
49. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419 [TBL] [Abstract][Full Text] [Related]
50. Liver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administration. Han X; Wang Z; Wang M; Li J; Xu Y; He R; Guan H; Yue Z; Gong M Drug Deliv; 2016 Jun; 23(5):1818-29. PubMed ID: 26556526 [TBL] [Abstract][Full Text] [Related]
51. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice. Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094 [TBL] [Abstract][Full Text] [Related]
52. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Shi L; Tang C; Yin C Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646 [TBL] [Abstract][Full Text] [Related]
54. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy. Xu C; Liu W; Hu Y; Li W; Di W Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871 [TBL] [Abstract][Full Text] [Related]
55. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer. Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816 [TBL] [Abstract][Full Text] [Related]
56. Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel. Ju C; Sun J; Zi P; Jin X; Zhang C J Pharm Sci; 2013 Aug; 102(8):2707-17. PubMed ID: 23839931 [TBL] [Abstract][Full Text] [Related]
57. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390 [TBL] [Abstract][Full Text] [Related]
58. Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery. Yoon HY; Koo H; Choi KY; Chan Kwon I; Choi K; Park JH; Kim K Biomaterials; 2013 Jul; 34(21):5273-80. PubMed ID: 23591396 [TBL] [Abstract][Full Text] [Related]
59. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy. Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166 [TBL] [Abstract][Full Text] [Related]
60. Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid. Tian Q; Wang XH; Wang W; Zhang CN; Wang P; Yuan Z Nanomedicine; 2012 Aug; 8(6):870-9. PubMed ID: 22100756 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]